New technology to analyze interactions between live cells
Micro-capsule technology for high-throughput analyses of cell-cell interactions
This study is exploring a new technology that helps scientists watch how millions of living cells interact with each other at the same time, which could lead to better ways to understand cell behavior and develop treatments for various health conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10853807 on NIH RePORTER |
What this research studies
This research focuses on developing a groundbreaking technology that allows for the analysis of millions of live cell-cell interactions simultaneously. By utilizing micro-capsules, which are semi-permeable compartments, the research aims to facilitate long-term cell growth and enable complex procedures like imaging and treatment in a high-throughput manner. This innovative approach could significantly enhance our understanding of cell communication and adhesion, with potential applications in screening antibodies and evaluating receptor interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve cell communication and adhesion issues, such as certain autoimmune diseases or cancers.
Not a fit: Patients with conditions unrelated to cell interactions or those who are not undergoing treatments that involve cellular therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies by improving our understanding of how cells interact and communicate.
How similar studies have performed: Other research has shown promise with high-throughput cell interaction analysis, but this specific micro-capsule technology represents a novel approach.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Klein, Allon Moshe — Harvard Medical School
- Study coordinator: Klein, Allon Moshe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.